Atlas Trials

A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients

Clinical trial NCT01972438 · TERMINATED

Trial details

NCT number
NCT01972438
Sponsor
National Eye Institute (NEI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft vs Host Disease
Start date
2013-11-01
Primary completion
2015-05-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.